Managing sleep apnoea correctly will lead to a more balanced & fulfilled lifestyle. It is estimated that over ten percent of the global population are suffering from sleep apnoea, & of this approximately only ten percent are currently being treated.
Santé are committed to providing sustainable & professional solutions to the valued sleep fraternity & are bringing the Löwenstein range of sleep devices to Australia. Löwenstein are a premium respiratory device manufacturer in Germany, having developed leading-edge technology in healthcare & homecare breathing support.
The thoroughly modern nasal & full face masks in the CARA family satisfy patient requirements for a perfect fit, great wearing comfort, gentle, quiet exhalation & good skin compatibility.
The successful CARA masks wins over fans with it’s lightness, the soft supple mask cushion, adjustable headgear, excellent fit and other clever details.
The German-made Löwenstein PrismaLINE (or Prisma range) consists of leading-edge sleep apnoea devices in the global market. All devices are warehoused & serviced locally, with a 5-year warranty.
With the help of a superior algorithm, the Prisma range of automatic devices provides continuous pressure adjustments tailored specifically to the patient's needs, providing highly effective treatment. Reportedly, users of the Prisma range experience superior & unique treatment benefits & overall comfort, we call this "The Löwenstein Difference", further insights into why these clinical benefits are present are explored below.
Introducing the SOMNObalance e APAP/CPAP Treatment device & SOMNOsoft2e CPAP device from the trusted SOMNO range by Löwenstein. These are made in Germany and offer superior quality & durability, in a simple but very functional device.
Both devices feature the integrated highly efficient SOMNOaqua humidifier with adjustable humidification settings, SoftPAP, SoftStart & auto start/stop. SOMNObalance e APAP/CPAP device also has an efficacious APAP treatment algorithm that proactively optimises the night's sleep & has an adjustable rate of pressure change.
There are tangible benefits for our distribution network taking up this new product, including but not limited to;
The Löwenstein devices consistently demonstrate clinical efficacy (AHI<5/hour), with further key clinical features as follows:
There is no set formula for the successful treatment of sleep disordered breathing (i.e. obstructive sleep apnoea). The treatment process is a complex matter & intensely individual, when it comes to PAP therapy, a practical test & trial process fine-tuned & tailored to an individual’s experience & needs by a trained professional is the consistent way to optimise the treatment outcome.
When asked what defines successful sleep apnoea treatment, the usual metric clinicians & specialists refer to is AHI (Apnoea Hypopnea Index) per hour. A score of less than 5 AHI/hr is the typical theoretical definition of clinical effectiveness in PAP therapy. In reality, therapy outcome revolves around more than AHI/hr. The following chart offers insight into how Santé & Löwenstein view therapy success.
Preheat function is activated via pressing the humidifier symbol once, prior to commencement of therapy. If you forget, SAC will boost heat at start-up to quickly bring humidification. SAC intelligently regulates humidity to keep it as constant as possible even if your mask leaks.